Quick balloon treatment may reduce severe bleeding after delivery
NCT ID NCT02226731
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether placing a balloon in the uterus early (within 15 minutes) helps control heavy bleeding after vaginal birth better than waiting 30 minutes. It included 405 women who had persistent bleeding after standard medication. The goal was to see if early balloon use reduces the need for blood transfusions or severe blood loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Belfort-Dildy balloon catheter (a device placed in the uterus to stop bleeding)
What this could lead to
If early balloon use works better, it could become a standard step to control severe postpartum bleeding and reduce the need for blood transfusions.
What could go wrong
This is a completed trial, but the benefit of early versus late balloon use may be small or not apply to all hospitals. The device itself carries risks like infection or injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMEDIATE POSTPARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHI de Poissy Saint Germain en Laye
Poissy, 78303, France